发明名称 COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE
摘要 The disclosure relates to obeticholic acid formulations with improved stability, dissolution, and/or solubility, methods of preparing the same for use and methods of treating various diseases and conditions.
申请公布号 US2017035784(A1) 申请公布日期 2017.02.09
申请号 US201615139138 申请日期 2016.04.26
申请人 Intercept Pharmaceuticals, Inc. ;Sumitomo Dainippon Pharma Co., Ltd. 发明人 Lancaster Richard Gail;Olmstead Kay K.;Kagihiro Masashi;Matono Mitsuhiro;Taoka Ikuko;Pruzanski Mark;Shapiro David;Hooshmand-Rad Roya;Pencek Richard;Sciacca Cathi;Eliot Lise;Edwards Jeffrey;MacConell Leigh A.;Marmon Tonya K.
分类号 A61K31/575;A61K45/06;A61K9/20 主分类号 A61K31/575
代理机构 代理人
主权项 1. A composition comprising obeticholic acid, or a pharmaceutically acceptable salt, ester, or amino acid conjugate thereof, wherein obeticholic acid or a pharmaceutically acceptable salt, ester, or amino acid conjugate thereof is in the form of particles, and wherein at least 50% of the particles have a diameter of 200 μm or less.
地址 New York NY US